background image


PE Hub Network: Neuro-pharmaceutical firm MindMed raises funding

“Psychedelics have been governed by unfounded bias and prohibition. I believe they may hold as much or more therapeutic promise as cannabis,” said Linton. “It is very clear that psychedelics need to be regulated by the FDA, and I believe MindMed has both the team and strategy to conduct the necessary trials and create next-generation psychedelics.


read the full pehub article